Oligonucleotide Synthesis Market - Trends Forecast Till 2028

Oligonucleotide Synthesis Market, by Product (Drug, Synthesized Oligos (Primer, Probe), Reagents), Type (Custom, Predesign), Application (Therapeutic (ASO, siRNA), Research (PCR), Diagnostic), End User (Hospital, Pharma, CROs) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Published Date: June, 2021

Base Year Estimate: 2020

Report ID: D-HC-OSM-226

Format:  

Number of Pages: 486

Domain: Healthcare

Oligonucleotide Synthesis Market - Trends Forecast Till 2028

The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6% during the forecast period.

Increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine are the major factors that have supported long term expansion of Global Oligonucleotide Synthesis Market.

Global Oligonucleotide Synthesis Market

Global Oligonucleotide Synthesis Market is segmented into product, application, end user and geography.

Product segment is segmented into oligonucleotide-based drugs, synthesized oligonucleotide, reagents and equipment. 

Application segment is segmented into therapeutic applications, therapeutic applications by disease type, diagnostic application and research applications.

End user segment is segmented into hospitals, pharmaceuticals & biotechnology companies, diagnostic laboratories, contract research organizations and contact manufacturing organizations (CROS & COMS) and academic research institutes.

Geographically, Global Oligonucleotide Synthesis market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Key players in Global Oligonucleotide Synthesis market are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).

Available Customizations

In addition to the market data for Global Oligonucleotide Synthesis market, Delvens. offers client-centric report and customized according to the company’s specific demand and requirement.

Research methodology

Secondary research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conference like Jefferies conference)—to identify and collect information useful for this study of the Oligonucleotide synthesis market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial study the global Oligonucleotide synthesis market. Through secondary the market is classified and segmented as per of industry trend, development, regional market. Product and technology development.

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. 

The primary Respondent breakdown is given below:

Primary Respondents

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validating the total revenue of the oligonucleotide synthesis market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation 

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondent in order to gain 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for oligonucleotide synthesis market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report scope

 

Report feature 

Descriptions

Market revenue in 2021

USD 6.3 billion 

Growth rate

CAGR of 17.6% during the forecast period

Historical data

2018-2019

Forecast years

2021-2028

Base year

2020

Units considered

Revenue in USD billion

Report segmentation

product, application, end user and geography

Report attribute 

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional level scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country level scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies profiled 

Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).

Available customizations

In addition to the market data for Global Oligonucleotide Synthesis market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.